PT-16

N/A

Report date: 2024/12/02 11:06:00

Base Information

Drug NamePT-16
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUrokinase plasminogen activator modulators
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPalatin Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPalatin Technologies Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A